Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AHMED A., MARSHALL P. B. Relationship between anti-acetylcholine and anti-Tremorine activity in anti-parkinsonian and related drugs. Br J Pharmacol Chemother. 1962 Apr;18:247–254. doi: 10.1111/j.1476-5381.1962.tb01405.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BARCROFT H., PETERSON E., SCHWAB R. S. Action of adrenaline and noradrenaline on the tremor in Parkinson's disease. Neurology. 1952 Mar-Apr;2(2):154–160. doi: 10.1212/wnl.2.5-6.154. [DOI] [PubMed] [Google Scholar]
- CARLSSON A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev. 1959 Jun;11(2 Pt 2):490–493. [PubMed] [Google Scholar]
- CARMICHAEL E. A., FELDBERG W., FLEISCHHAUER K. The site of origin of the tremor produced by tubocurarine acting from the cerebral ventricles. J Physiol. 1962 Aug;162:539–554. doi: 10.1113/jphysiol.1962.sp006949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CONSTAS C. The effects of adrenaline, noradrenaline, and isoprenaline on parkinsonian tremor. J Neurol Neurosurg Psychiatry. 1962 May;25:116–121. doi: 10.1136/jnnp.25.2.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DEWS P. B. The measurement of the influence of drugs on voluntary activity in mice. Br J Pharmacol Chemother. 1953 Mar;8(1):46–48. doi: 10.1111/j.1476-5381.1953.tb00749.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GILLESPIE L., Jr, OATES J. A., CROUT J. R., SJOERDSMA A. Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension. Circulation. 1962 Feb;25:281–291. doi: 10.1161/01.cir.25.2.281. [DOI] [PubMed] [Google Scholar]
- HARA S., KAWAMORI K. Pharmacological studies on the function of the extrapyramidal system. 2. Mechanism of the appearance of tremor due to extrapyramidal poisons. Jpn J Pharmacol. 1954 Mar;3(2):149–156. doi: 10.1254/jjp.3.149. [DOI] [PubMed] [Google Scholar]
- HESS S. M., CONNAMACHER R. H., OZAKI M., UDENFRIEND S. The effects of alpha-methyl-DOPA and alpha-methyl-metatyrosine on the metabolism of norepinephrine and serotonin in vivo. J Pharmacol Exp Ther. 1961 Nov;134:129–138. [PubMed] [Google Scholar]
- JENKNER F. L., WARD A., Jr Bulbar reticular formation and tremor. AMA Arch Neurol Psychiatry. 1953 Oct;70(4):489–502. [PubMed] [Google Scholar]
- MARSH D. O., SCHNIEDEN H., MARSHALL J. A CONTROLLED CLINICAL TRIAL OF ALPHA METHYL DOPA IN PARKINSONIAN TREMOR. J Neurol Neurosurg Psychiatry. 1963 Dec;26:505–510. doi: 10.1136/jnnp.26.6.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PORTER C. C., TOTARO J. A., LEIBY C. M. Some biochemical effects of alpha-methyl-3,4-dihydroxyphenylalanine and related compounds in mice. J Pharmacol Exp Ther. 1961 Nov;134:139–145. [PubMed] [Google Scholar]
- WESTERMANN E., BALZER H., KNELL J. Hemmung der Serotoninbildung durch alpha-Methyl-Dopa. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;234(3):194–205. [PubMed] [Google Scholar]
- ZETLER G. Der Harmin-Tremor und seine Antagonisten. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1957;231(1):34–54. [PubMed] [Google Scholar]